Peter M. Hecht - 03 Jun 2021 Form 4 Insider Report for Cyclerion Therapeutics, Inc. (CYCN)

Role
Chief Executive Officer, Director
Signature
/s/ Gary J. Simon, Attorney-in-Fact
Issuer symbol
CYCN
Transactions as of
03 Jun 2021
Net transactions value
+$2,699,998
Form type
4
Filing time
07 Jun 2021, 17:25:44 UTC
Previous filing
10 May 2021
Next filing
24 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYCN Common Stock Purchase $2,699,998 +823,170 +67% $3.28 2,047,698 03 Jun 2021 Direct F1
holding CYCN Common Stock 485 03 Jun 2021 The 2000 Trust for Alexis Mae Hecht F2
holding CYCN Common Stock 485 03 Jun 2021 The 2000 Trust for Malcolm Paul Hecht F2
holding CYCN Common Stock 485 03 Jun 2021 The 2000 Trust for Zoe Niovi Hecht F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 3, 2021, the reporting person agreed to purchase directly from the Issuer 823,170 shares of Common Stock of the Issuer in a private placement transaction.
F2 These shares are held in the referenced trust for the benefit of the reporting person's child. The reporting person's spouse is the trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or any other purpose.